Skip to main content
. 2018 Dec 31;13(12):e0206907. doi: 10.1371/journal.pone.0206907

Table 4. Comparison of outcomes for continuous laboratory variables at week 48 between treatment groups.

Parameter PLC group CTX group P-value
Baseline CD4 count mean (s.d.) 518.6 (198.8) 519.6 (192.4) <0.001
Week 48 CD4 count mean (s.d.) 531.2 (200.9) 506.3 (188.8)
Marginal mean at week 48 (95% c.i.) 498.2 (491.0; 505.5) 472.4 (466.0; 479.7)
Baseline WBC count mean (s.d.) 4.64 (1.47) 4.61 (1.40) <0.001
Week 48 WBC count mean (s.d.) 4.59 (1.40) 4.24 (1.37)
Marginal mean at week 48 (95% c.i.) 4.39 (4.32; 4.46) 4.05 (3.99; 4.11)
Baseline neutrophil count mean (s.d.) 1.82 (0.89) 1.78 (0.89) <0.001
Week 48 neutrophil count mean (s.d.) 1.87 (0.95) 1.69 (0.90)
Marginal mean at week 48 (95% c.i.) 1.67 (1.63; 1.72) 1.51 (1.47; 1.55)
Baseline Hb count mean (s.d.) 13.36 (1.45) 13.31 (1.47) 0.33
Week 48 Hb count mean (s.d.) 13.36 (1.55) 13.26 (1.51)
Marginal mean at week 48 (95% c.i.) 13.33 (13.27; 13.40) 13.29 (13.24; 13.34)
Baseline platelets count mean (s.d.) 261.5 (68.8) 262.5 (72.9) 0.18
Week 48 platelets count mean (s.d.) 258.2 (74.7) 263.3 (73.2)
Marginal mean at week 48 (95% c.i.) 253.6 (250.1; 257.0) 256.9 (253.6; 260.2)